Cranbrook Wealth Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Cranbrook Wealth Management's OGN Position: Q3 2026 in Review
Cranbrook Wealth Management sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 169 shares — an estimated $2.29K sold.
Cranbrook Wealth Management first reported a position in OGN in Q2 2021 and held it in 21 quarters. The position peaked at $7K in Q1 2022. 608 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Cranbrook Wealth Management reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
- Cranbrook Wealth Management sold 169 Organon & Co shares in Q3 2026, an estimated $2.29K.
- Cranbrook Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 21 quarters.
- Cranbrook Wealth Management's Organon & Co position peaked at $7K in Q1 2022.
- 608 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.